# Treatment of Executive Dysfunction in Parkinson's Disease

> **NCT00286949** · NA · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 12 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Atomoxetine

## Key facts

- **NCT ID:** NCT00286949
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01-06
- **Primary completion:** 2008-06-30
- **Final completion:** 2008-06-30
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00286949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00286949, "Treatment of Executive Dysfunction in Parkinson's Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00286949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*